For my first post, I’m sharing a letter @NVIDIA signed on why open models matter.
AI will transform every industry, power every company, and be built by every country.
Open models strengthen safety and cybersecurity, accelerate innovation and diffusion, and enable sovereignty.
The world needs both frontier closed models and frontier open models.
https://t.co/AUKzoQ5Ikb
Infinita is proudly declaring its support for the "Faster Clinical Trials Act", a bipartisan bill introduced by Reps.
@JakeAuch (D-MA) and @RepMGriffith (R-VA).
Clinical trial reform at the federal level has suffered from a lack of ambition.
This is the first bill that I've seen that is not lacking ambition whatsoever.
"The bill also sets targets to reduce the cost per patient for the clinical trials conducted by these networks by 30 to 50 percent and speed participant enrollment in those trials by 30 percent."
The mechanisms how to reduce costs are a distillation best policy research that I've seen over the years, incl. by @IFP, @RuxandraTeslo, @sytses & many more
The things I am most excited about:
- Bringing evidence generation closer into the clinic; proving real-world effectiveness has been an afterthought in FDA approvals, leading to lack of safety & efficacy
- Streamlined trial site networks that can be accessed via a "multi-site, single-IRB", overcoming the IRB fragmentation that is a major source of delay in early research
- Governance sandboxes - critically, the bill does not make the mistake of trying to fix everything at once. Its mandate is to support sandboxes, innovative trial models
With this, the US has a real shot at retaining its competitive advantage in biotech, and could do right by millions of patients to access trials in the US instead of abroad.
It feels like a failure. Maybe it is. I am sunsetting DeSci Reviews: an experiment with a negative result. In science, a negative result is still a result. So I’m reporting this one the way I’d report any other.
Socialists discovered that corporations have too much power and proposed merging your employer, landlord and grocery store into one institution with a police force and military.
This framing assumes over prioritising safety has no downside. It means telling a stage 4 cancer patient they can’t take a drug that passed a phase 3 trial, and must die of their cancer instead, while experts debate how it works. It’s their body and their choice.
For that patient the choice isn’t wait safely vs take a risky drug. It’s die waiting vs a chance of living. That’s why patients already inject untested compounds at unregulated clinics in Mexico.
Millions die while we wait and nobody gets blamed. If 100 people died from an AI designed drug it would be called a catastrophe, even though most of them would have been dead within months anyway.
Patients know new drugs can go wrong. The alternative is extreme suffering or death. We aren’t impatient because we want the next shiny update, we’re impatient because many of us will die before it arrives.
Drug regulation is already too strict. With AI now moving biology this fast, the priority should be loosening it, not tightening it. Right now a patient who will die from their disease in a few months, or take their own life because of the suffering, usually can’t get access to promising drugs still in trials or try combinations that might work better together but carry more side effect risk. They just have to die.
If we were being logical, those patients could enroll in a program, try the drug or any combination they want, and record the outcome so it feeds back into the science. Relying on slow, admin heavy trials with tightly selected groups as the only way to learn about new treatments is the least efficient and least ethical option we have. It exists to protect pharma and regulators from blame, not to reduce suffering and death. Now that some people could realistically be cured in the next decade instead of waiting 20 years for trial funding and long term outcome studies, we should be moving away from it fast.
For weight loss or baldness, be as rigorous as you like. Framing this around stage 4 cancer is detached from what patients actually face. The people debating it don’t pay for the delay, the patient does.
@MikePElston@ehrlichman61341@politicsusa46 Corporations who have the most money inevitably convert this to power to write their own regulations and direct government resources to themselves. What is the solution to that?
@michaelmoran So government courts conveniently grant the government sovereign immunity. Could you please create a court of humanity so we can file a class action lawsuit via an independent body?
Scientific data does show a notable, population-wide shift in human behavior and personality traits following the pandemic. Here are two prominent studies for your review, plus the Pew Research Center Study, thrown in for extra measure.
1. The FSU College of Medicine "Pandemic Personality" Study
The Findings: The study found statistically significant population-wide declines in Agreeableness (the capacity for empathy, trust, sympathy, and cooperation) and Extraversion (sociability and the desire to seek out others' company) by 2021/2022. The shifts were so severe that researchers stated the population experienced the equivalent of a decade of normal personality alteration compressed into just two years. Younger adults were hit hardest, showing sharp increases in neuroticism paired with a steep drop in overall friendliness and compliance with social norms.
2. The College Student Cognitive Empathy Study. The Study: Published in the Journal of American College Health (2022), this longitudinal study tracked college students' psychological well-being and empathic capacity immediately before and during the pandemic phases.
The Findings: The researchers observed a significant decline in cognitive empathy (the psychological capacity to take another person's perspective or understand their mental and emotional state). This degradation of perspective-taking directly mirrors the "colder" and more "detached" behavior observed in the general public, as individuals became structurally less capable of processing or caring about the experiences of those around them while battling their own chronic stress and isolation.
The Pew Research Center also reveals that 47% of American adults explicitly report that public human behavior became significantly ruder and more aggressive since the onset of the pandemic.
We need a global framework for pragmatic clinical trials so every patient can participate in any trial for the most promising treatment through their doctor and have their EHR data continuously update treatment rankings and outcome labels for every treatment. Like the RECOVERY trial for every disease.
If you want to understand why healthcare is so expensive, I'd start with a Supreme Court case about teeth whitening.
Around 2003, spas and small kiosks in North Carolina were offering teeth whitening for a fraction of what dentists charge.
So dentists complained to the state dental board. That dental board looks like this:
- 6 of 8 are practicing dentists, elected by other dentists
- 8 of the 10 who sat on the board during this period earned substantial fees from whitening
The board sent 47+ cease-and-desist letters, warning non-dentists that they're committing a crime by practicing dentistry without a license. The board also sent letters to mall operators, advising them to expel whitening kiosks.
All this worked! These kiosks shut down, prices stayed high, dentists stayed happy.
Regulatory capture like this exists all over in healthcare. What makes this case notable is that someone actually sued the NC dental board, in a case that went all the way to the supreme court.
In a 6-3 ruling, the SC ruled that if a board is run by those who participate in the market without proper supervision - that looks like a cartel, therefore, antitrust law applies.
I have to believe there are so many other potential cases like this in healthcare, just waiting to be pressed on. I'd love to see more of this.
FDA approval does not prove a drug works. That's a myth.
There is a difference between efficacy and effectiveness:
- Efficacy = the drug beat placebo in a trial. A technical term. It's what FDA approval certifies.
- Effectiveness = the drug works in the real patient population
And there is a well-studied gap between efficacy and effectiveness.
Science Alert: 'Brain Scans of 24 People With Long COVID Reveal Signs of Injury to Dopamine Neurons'
"Our findings provide compelling evidence that long COVID involves the loss of dopamine-releasing neurons"
https://t.co/p5EdF7g596
Have you taken notice of how America makes the people that it claims to "liberate" suffer immensely?
Remember the 500,000 dead Iraq children (from sanctions) that America's U.S. Ambassador to the UN said was "worth it"? Then came the invasion of that same country. Iraq had nothing to do with 9/11 and that had no WMD's!
Or how about the poor Cuban people that are suffering immensely (right now) from the blockade of Cuba?
How about the Iranian people, who are added to the list of those who suffer from America's invasion, blockade and sanctions?
It's never about "liberation" or "freedom." How can it be, when the very same people take away as many freedoms of OURS that they possibly can?
Watch @RonPaul & @ChrisRossini below:
Today is International Longevity Day.
At Lifespan Research Institute, we’re working toward a future where growing older doesn’t have to mean an ever-increasing burden of disease.
That future won’t come from a single discovery. It takes an ecosystem.
At LRI, we work across that ecosystem to drive the field forward on multiple fronts:
📰 Educating through thousands of articles and resources
📈 Catalyzing millions in longevity biotech investment
🔬 Translating research toward the clinic
🤝 Building tools, advocacy & collaborations
With your support, we can do even more, from expanding our Rejuvenation Roadmap and advancing therapies targeting mitochondrial dysfunction and senescent cells, to developing digital biomarkers that can help us better measure human aging and building the connections that turn promising science into real-world impact.
At a time when the future is so often defined by what may go wrong, we believe it’s worth investing in what can go right.
If you believe a healthier future is worth building, stand with LRI this International Longevity Day.
💙 Support our work: https://t.co/9FFo9Du2Bk
We welcome one-time and recurring donations, gifts of stock, cryptocurrency, and through donor-advised funds. For larger gifts or matching support, please contact [email protected]
#InternationalLongevityDay #LongevityResearch #HealthyLongevity